THERALINK TECHNOLOGIES, INC.
company.status.inactiveCIK 1362703fmd_04NY6K74AW24PTAM5Y9JSH918R制造业 · 医药制剂模板: 标准
覆盖范围: 2006年3月01日 至 2023年12月31日，共 63 个期间
| 项目 | FY2016 | FY2017 | FY2018 | FY2019 | FY2019 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | – | – | – | – | – | – | 0 | 1 | 1 | 1 |
| 租金收入 | – | – | – | – | – | – | – | – | 0 | – |
| 营业成本 | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| 毛利润 | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| 研发费用 | 0 | 0 | 0 | 0 | – | 0 | – | – | – | – |
| 销售、一般及管理费用 | – | – | – | – | – | – | – | – | 0 | 0 |
| 薪酬与福利 | – | – | – | – | – | – | – | – | – | – |
| 营业费用合计 | 1 | 2 | 2 | 2 | – | – | 3 | 6 | 12 | 9 |
| 营业利润 | (1) | (2) | (2) | (2) | – | – | (3) | (6) | (12) | (9) |
| 利息费用 | 0 | 0 | 1 | 2 | – | – | 0 | 0 | 1 | 17 |
| 其他营业外收入（支出） | (0) | (0) | (12) | 8 | – | – | 0 | 0 | (1) | (22) |
| 所得税费用 | – | – | – | – | – | – | – | – | – | – |
| 持续经营净利润 | – | (2) | (15) | 6 | – | (9) | – | – | – | – |
| 净利润 | (1) | (2) | (21) | 6 | – | – | (3) | (5) | (13) | (31) |
| 归属于普通股股东的净利润 | – | – | – | – | (2) | – | (5) | (7) | (13) | (31) |